Andere talen Calian Group Ltd.

Aandelen

CGY

CA12989J1084

Beurs gesloten - Toronto S.E. Andere beurzen 21:53:52 22-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
55,52 ^CAD	+1,22%		+1,39%	-3,09%

27/03	Calian kondigt de benoeming aan van Valérie Travain-Milone tot President, Advanced Technologies	CI
21/03	Calian Group Ltd. levert simulatietechnologie voor spectruminterferentie aan het Canadese Ruimteagentschap	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Calian Group Brief: Appointing Valerie Travain-Milone as President, Advanced Technologies (AT)	27/03
Calian Announces the Appointment of New President of Advanced Technologies	27/03
Calian Announces the Appointment of Valérie Travain-Milone as President, Advanced Technologies	27/03
Correction: -- Calian Group Brief: Says to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian Group Says to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian Group and MDA Brief: Says to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian Group Ltd. to Deliver Spectrum Interference Simulation Technology for the Canadian Space Agency	21/03
Calian : Named to CRN’s 2024 Tech Elite 250 List	19/03
Calian : to Support NATO SHAPE in Development and Execution of Military Training Program	14/03
North American Morning Briefing : Stock Futures Rise Ahead of Powell's Testimony	06/03
Calian Group and MDA Brief: Calian Says "Strengthens Nuclear Capability" with Acquisition of MDA Ltd. Nuclear Assets	05/03
Calian renforce sa capacité nucléaire avec l’acquisition des actifs nucléaires de MDA Ltd.	05/03
Calian Strengthens Nuclear Capability with Acquisition of MDA Ltd. Nuclear Assets	05/03
Calian Group Ltd. acquired Assets And Nuclear Services of MDA Ltd.	05/03
Calian Group Says Won Contract to Support Clinical Trial for ZYUS Life Sciences' Lead Drug Product Candidate	20/02
Calian Group Brief: Says Won Contract to Support Clinical Trial for ZYUS Life Sciences' Lead Drug Product Candidate	20/02
Calian remporte un contrat pour soutenir l’essai clinique du principal médicament candidat de ZYUS Life Sciences	20/02
Calian Wins Contract to Support Clinical Trial for ZYUS Life Sciences’ Lead Drug Product Candidate	20/02
Calian Group Ltd. Wins Contract to Support Clinical Trial for Zyus Life Sciences? Lead Drug Product Candidate	20/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Calian Group Ltd.

Aandelen

CGY

CA12989J1084

Andere talen

Filters